Daiwa Securities Group Inc. Blueprint Medicines Corp Call Options Transaction History
Daiwa Securities Group Inc.
- $21.6 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
349Shares Held
60.2MCall Options Held
1.05MPut Options Held
616K-
Vanguard Group Inc Valley Forge, PA6.68MShares$639 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$636 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$515 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$379 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$265 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.71B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...